ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
| 0.8201 Delayed Data As of Jan 21 |  -0.0409 / -4.75%Today’s Change | 0.82 Today|||52-Week Range 5.95 | -24.76% Year-to-Date |
Latest ZIOP News | Press Releases
| Why Ziopharm Oncology Shares Rose 10.5% on Wednesday Jan 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.86 |
| Today’s open | 0.86 |
| Day’s range | 0.82 - 0.88 |
| Volume | 59,038 |
| Average volume (3 months) | 2,282,748 |
| Market cap | $176.6M |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +45.61% |
| Earnings growth (this year) | -4.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTEMMolecular Templates ... | -0.12 | -3.68% |
| SURFSurface Oncology Inc | -0.21 | -5.34% |
| URGNUrogen Pharma Ltd | -0.19 | -2.43% |
| LPTXLeap Therapeutics In... | -0.28 | -11.72% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 24, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$80.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
